Cendakimab
- Generic Name
- Cendakimab
- Drug Type
- Biotech
- Unique Ingredient Identifier
- O8R9U9ZUVN
Overview
Cendakimab is a recombinant humanized anti-interleukin 13 (IL-13) monoclonal antibody.
Background
Cendakimab is a recombinant humanized anti-interleukin 13 (IL-13) monoclonal antibody.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath